Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
11/04/2020 | Oric Pharmaceuticals, Inc. | ORIC | Sale | Common Stock | 2.3M | $0.00 | $0 | See Footnote | 11/04/2020 |
05/26/2020 | RAPT Therapeutics, Inc. | RAPT | Sale | Common Stock | 2.1M | $0.00 | $0 | Footnote | 05/26/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Common Stock | 231.2k | $0.00 | $0 | | 04/28/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Common Stock | 497.8k | $0.00 | $0 | | 04/28/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Common Stock | 314.8k | $0.00 | $0 | | 04/28/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Common Stock | 2.3M | $0.00 | $0 | See footnote | 04/28/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Series B Preferred Stock | 231.2k | $0.00 | $0 | | 04/28/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Series C Preferred Stock | 497.8k | $0.00 | $0 | | 04/28/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Series D Preferred Stock | 314.8k | $0.00 | $0 | | 04/28/2020 |
04/28/2020 | Oric Pharmaceuticals, Inc. | ORIC | Conversion | Series B Preferred Stock | 2.3M | $0.00 | $0 | See footnote | 04/28/2020 |
11/04/2019 | RAPT Therapeutics, Inc. | RAPT | Conversion | Series C-2 Preferred Stock | 155.2k | $0.00 | $0 | | 11/04/2019 |
11/04/2019 | RAPT Therapeutics, Inc. | RAPT | Conversion | Series C Preferred Stock | 363.5k | $0.00 | $0 | | 11/04/2019 |
11/04/2019 | RAPT Therapeutics, Inc. | RAPT | Conversion | Series B Preferred Stock | 1.6M | $0.00 | $0 | See footnotes 2, 3 and 4 | 11/04/2019 |
11/04/2019 | RAPT Therapeutics, Inc. | RAPT | Purchase | Common Stock | 415k | $12.00 | $5M | See Footnote | 11/04/2019 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Common Stock | 445.3k | $0.00 | $0 | | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Common Stock | 1.3M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Common Stock | 54.8k | $0.00 | $0 | By MSSB C/F Leo A. Guthart | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E Preferred Stock | 177.8k | $0.00 | $0 | | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E-1 Preferred Stock | 173.4k | $0.00 | $0 | | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series F Preferred Stock | 4.5M | $0.00 | $0 | | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E Preferred Stock | 6.2M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E-1 Preferred Stock | 6.1M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E Preferred Stock | 266.7k | $0.00 | $0 | By MSSB C/F Leo A. Guthart | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E-1 Preferred Stock | 260.1k | $0.00 | $0 | By MSSB C/F Leo A. Guthart | 07/23/2018 |